20.07.2017
- The European Commission has accused Israeli drugmaker Teva and its US subsidiary Cephalon of breaching antitrust rules. Regulators classed an agreement between the companies to...
29.05.2015
- Just before trial proceedings were to begin in a long-running dispute between the US Federal Trade Commission (FTC) and drugmaker Cephalon - now a subsidiary of Teva - the Israeli...
24.07.2013
- A U.S. Supreme Court ruling giving regulators the right to sue drugmakers for agreements that delay sale of cheaper generic pharmaceuticals should deter some of the most egregious...
23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
01.11.2012
- Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...
11.05.2011
- Teva Pharmaceutical Industries, the world's largest generic drugmaker, met forecasts with a 14% rise in quarterly earnings on strong sales growth in Europe following last year's...
04.05.2011
- Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...
29.03.2011
- Cephalon has offered to buy the Australian company ChemGenex Pharmaceuticals for about $231 million, or 225 Australian dollars. Cephalon's bid "has the unanimous support of the...
